Mechanical pressure is the central driver of most plantar diabetic foot ulcers. When peripheral neuropathy removes the protective sensation of pain, repetitive load on a bony prominence during walking produces tissue breakdown that the patient never feels. For this reason, relieving that pressure—a practice clinicians call offloading—is not an optional adjunct to wound care but the foundation on which every other treatment depends. Even meticulous debridement, infection control, and advanced dressings rarely succeed if the wound continues to bear weight with each step.
Why Offloading Determines Whether a Wound Heals
A neuropathic ulcer sits in a mechanical environment fundamentally different from that of an ordinary wound. The plantar surface is designed to absorb force, and in a foot that has lost sensation and often gained deformity, peak pressures concentrate over a small area. Continued loading disrupts the fragile cellular activity at the wound bed and perpetuates inflammation. Systematic review evidence has consistently identified offloading as the single most important factor in achieving closure of plantar diabetic foot ulcers, with the choice and consistency of the device strongly predicting healing time and the reduction in ulcer size (de Oliveira & Moore, Journal of Wound Care, 2015).
The Total Contact Cast and the Evidence Behind It
The total contact cast (TCC) is widely described as the gold standard for offloading neuropathic plantar ulcers. It is a well-molded, minimally padded cast that distributes weight across the entire plantar surface and lower leg, reducing pressure at the ulcer site while allowing the patient to remain mobile. Its decisive advantage is that it cannot be removed by the wearer, which guarantees that the foot is offloaded during every step rather than only when the patient chooses.
That feature matters because adherence is the recurring weak point in foot ulcer care. Devices the patient can take off are frequently left off, and pressure relief that happens only part of the time produces only partial results. The 2023 guidelines of the International Working Group on the Diabetic Foot (IWGDF), developed through systematic review and meta-analysis under the GRADE framework, accordingly give their strongest recommendation to a non-removable, knee-high offloading device—a total contact cast or a walker rendered irremovable—as first-line treatment for a plantar neuropathic forefoot ulcer (Bus et al., Diabetes/Metabolism Research and Reviews, 2023). Earlier multidisciplinary guidance from the Society for Vascular Surgery, the American Podiatric Medical Association, and the Society for Vascular Medicine reached the same conclusion, recommending offloading with a total contact cast or an irremovable fixed-ankle walking boot for plantar diabetic foot ulcers (Hingorani et al., Journal of Vascular Surgery, 2016).
Removable Versus Irremovable Devices
An instructive randomized comparison helps clarify why irremovability, rather than the cast itself, drives outcomes. When a total contact cast was compared with a walking boot that was rendered irremovable and with the same boot left removable, healing times did not differ significantly between the groups; the removable device was simply more comfortable, less costly, and better accepted by patients, while the cast group reported more minor adverse events (Piaggesi et al., Foot & Ankle International, 2016). The practical message is that a properly fitted knee-high device, kept on consistently, is what heals the wound—whether that consistency is achieved by a cast or by making a boot non-removable.
The Persistent Gap Between Evidence and Practice
Despite this clear evidence base, gold-standard offloading remains substantially underused. A survey of Swedish prosthetic and orthotic clinics found that the great majority of practitioners treated plantar neuropathic forefoot ulcers with modified footwear and insoles—an approach the IWGDF specifically recommends against—while total contact casts were provided by only a fifth of clinics and non-removable knee-high walkers by none. Many practitioners were unaware that the cast and the non-removable walker are considered the standard of care (Gigante et al., Diabetes/Metabolism Research and Reviews, 2023). The barriers are familiar: casting is technically demanding and time-consuming to apply, and both patients and clinicians may resist a bulky, non-removable device. Closing this gap is one of the more achievable opportunities to improve healing rates.
Offloading in Active Charcot Neuroarthropathy
Offloading is equally central to managing active Charcot neuro-osteoarthropathy, where immobilization protects a foot whose bones and joints are inflamed and vulnerable to collapse. A cohort study of patients with active Charcot foot found that beginning total contact casting at the earliest inflammatory phase (stage 0), before fractures or deformity were established, was associated with shorter total casting duration, a lower risk of a new Charcot event, and a reduced need for reconstructive surgery compared with later treatment (Schoug et al., Diabetes Care, 2024). The finding reinforces a broader principle: pressure relief delivers the most benefit when it is applied early and maintained continuously.
Key Takeaways
Offloading is the decisive intervention in healing plantar diabetic foot ulcers and in protecting the foot during active Charcot neuroarthropathy. Current evidence and international guidelines favor non-removable, knee-high devices—the total contact cast or an irremovable walker—because consistent, full-time pressure relief, more than the specific device, is what drives wound closure. The principal challenge is not a lack of evidence but its translation into everyday practice, where effective offloading is still applied less often than the data warrant.
References
Bus SA, Monteiro-Soares M, Game F, et al. Standards for the development and methodology of the 2023 IWGDF guidelines. Diabetes/Metabolism Research and Reviews. 2023;40(3):e3656.
Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of Vascular Surgery. 2016;63(2 Suppl):3S-21S.
de Oliveira ALM, Moore Z. Treatment of the diabetic foot by offloading: a systematic review. Journal of Wound Care. 2015;24(12):560-570.
Piaggesi A, Goretti C, Iacopi E, et al. Comparison of removable and irremovable walking boot to total contact casting in offloading the neuropathic diabetic foot ulceration. Foot & Ankle International. 2016;37(8):855-861.
Gigante I, Sigurjónsdóttir ED, Jarl G, Hellstrand Tang U. Offloading of diabetes-related neuropathic foot ulcers at Swedish prosthetic and orthotic clinics. Diabetes/Metabolism Research and Reviews. 2023;39(4):e3611.
Schoug J, Katzman P, Fagher K, Löndahl M. Charcot Foot Offloading in Stage 0 Is Associated With Shorter Total Contact Cast Treatment and Lower Risk of Recurrence and Reconstructive Surgery: A Pilot Study. Diabetes Care. 2024;47(2):252-258.
Comments
